Pharmacokinetic Profile of a Low-Molecular Weight Heparin (Reviparin) in Pregnant Patients: A Prospective Cohort Study
- 15 April 2000
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 98 (2) , 133-138
- https://doi.org/10.1016/s0049-3848(99)00228-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- 5 Anticoagulants in pregnancy: fetal effectsBailliere's Clinical Obstetrics and Gynaecology, 1997
- 6 Hazards of heparin: allergy, heparin-induced thrombocytopenia and osteoporosisBailliere's Clinical Obstetrics and Gynaecology, 1997
- Low-Molecular-Weight Heparin in the Treatment of Patients with Venous ThromboembolismNew England Journal of Medicine, 1997
- Fragmin in Unstable Angina Pectoris or in Non-Q-Wave Acute Myocardial Infarction (the FRIC Study)The American Journal of Cardiology, 1997
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery DiseaseNew England Journal of Medicine, 1997
- The Effects of Long-term Heparin Therapy During Pregnancy on Bone DensityThrombosis and Haemostasis, 1996
- A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein ThrombosisNew England Journal of Medicine, 1996
- Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at HomeNew England Journal of Medicine, 1996
- Low-molecular-weight heparin during instability in coronary artery diseaseThe Lancet, 1996
- Prophylaxis of postoperative thromboembolism with low molecular weight heparinsBritish Journal of Surgery, 1993